Frontlight ResearchEarly access
Head and neck cancer trials in United States
391 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleToripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer
- Where
- Chicago
- Age
- 18 years and over
- People
- 30
- Run by
- University of Chicago
See details and how to joinNCT07290621 - No phaseTaking peopleImproving Care for Rural Patients With Solid Tumors
- Where
- Aurora, Colorado Springs, Fort Collins, Grand Junction, Greeley, Highlands Ranch, Loveland, Montrose, Pueblo, Salt Lake City, Steamboat Springs
- Age
- 18 years to 99 years
- People
- 320
- Run by
- University of Colorado, Denver
See details and how to joinNCT04916990 - Phase 2Taking peopleHPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma
- Where
- Charlottesville, Miami, Norfolk, Richmond
- Age
- 18 years and over
- People
- 90
- Run by
- University of Virginia
See details and how to joinNCT05962242 - No phaseTaking peoplePersonalized Ultrafractionated Stereotactic Adaptive Radiotherapy for Palliative Head and Neck Cancer Treatment (PULS-Pal)
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 43
- Run by
- Jonsson Comprehensive Cancer Center
See details and how to joinNCT06572423 - Phase 2Taking peopleA Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
- Where
- Ann Arbor
- Age
- 18 years and over
- People
- 150
- Run by
- University of Michigan Rogel Cancer Center
See details and how to joinNCT05894083 - Phase 1Taking peopleX-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
- Where
- Charlotte, Durham, Greenville, Washington D.C.
- Age
- 18 years and over
- People
- 52
- Run by
- Immunolight, LLC
See details and how to joinNCT04389281 - Phase 1Not yet taking people in United StatesLattice-Based Radiotherapy and Chemo-Immunotherapy for Oral Cavity Squamous Cell Carcinoma
- Where
- New York
- Age
- 18 years and over
- People
- 30
- Run by
- NYU Langone Health
See details and how to joinNCT07335380 - Early phase 1Taking peopleDrug Screening Using Novel IMD in Salivary and Head and Neck Cancers
- Where
- Boston
- Age
- 18 years and over
- People
- 30
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT05553782 - Phase 2CompletedStudy to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy
- Where
- Baltimore, Boca Raton, Easton, Fullerton, Lebanon, Los Angeles, Louisville, Madison, Miami, St Louis
- Age
- 18 years and over
- People
- 21 worldwide
- Run by
- NATCO Pharma Ltd.
See details and how to joinNCT05283226 - No phaseNot yet taking people in United StatesAccess to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC)
- Where
- Memphis, Orlando
- Age
- 18 years and over
- People
- 24
- Run by
- University of Tennessee
See details and how to joinNCT07225725 - Phase 2Not yet taking people in United StatesA Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck
- Where
- Chicago
- Age
- 18 years and over
- People
- 90
- Run by
- University of Chicago
See details and how to joinNCT07346196 - No phaseTaking peopleSample Collection for Ongoing Research and Product Evaluation Study
- Where
- Austin
- Age
- 18 years and over
- People
- 9,600
- Run by
- Natera, Inc.
See details and how to joinNCT07318051 - Early phase 1Taking peopleIntraoral Hypothermia Device for Preserving Taste During Radiation
- Where
- Detroit
- Age
- 18 years and over
- People
- 15
- Run by
- Henry Ford Health System
See details and how to joinNCT06579248 - Phase 2Taking peopleUse of SPY Imaging System to Minimize Fistulas After Hypopharyngeal Reconstruction
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 225
- Run by
- Matthew Spector
See details and how to joinNCT06831149 - Phase 1Taking peopleA Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Where
- Austin, Dallas, Denver, Fairfax, Greenville, Huntersville, Oklahoma City, Orlando, San Antonio, Sarasota
- Age
- 18 years and over
- People
- 96
- Run by
- Dren Bio
See details and how to joinNCT06999187 - Phase 2Taking peopleAdaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma
- Where
- New York
- Age
- 18 years and over
- People
- 120
- Run by
- NYU Langone Health
See details and how to joinNCT03215719 - Early phase 1Taking peopleComparison of 89Zr Panitumumab and (18)F-Fluorodeoxyglucose to Identify Head and Neck Squamous Cell Carcinoma
- Where
- Birmingham
- Age
- 18 years and over
- People
- 14
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT05183048 - No phaseTaking peopleIdentification and Characterization of Novel Proteins and Genes in Head and Neck Cancer
- Where
- Stanford
- Age
- 18 years and over
- People
- 500
- Run by
- Stanford University
See details and how to joinNCT00230308 - Phase 2Taking peoplePhase II Panitumumab-IRDye800 in Head & Neck Cancer
- Where
- Birmingham
- Age
- 18 years and over
- People
- 25
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT04511078 - Phase 1CompletedA Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
- Where
- Canton, Columbus, Dallas, Fairfax, Houston, Los Angeles, Pittsburgh, Tamarac
- Age
- 18 years and over
- People
- 168 worldwide
- Run by
- OncoNano Medicine, Inc.
See details and how to joinNCT06022029 - No phaseTaking peopleTongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck Cancer
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 35
- Run by
- Yvonne Mowery
See details and how to joinNCT07227792 - No phaseTaking peopleTumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma
- Where
- San Francisco
- Age
- 18 years and over
- People
- 250
- Run by
- University of California, San Francisco
See details and how to joinNCT06606028 - No phaseTaking peopleMulti-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
- Where
- Charleston, Durham, Houston, St Louis
- Age
- 18 years and over
- People
- 532
- Run by
- Medical University of South Carolina
See details and how to joinNCT05793151 - Phase 1/2Taking peopleA Study of MT-4561 in Patients With Various Advanced Solid Tumors
- Where
- Columbus, Grand Rapids, Houston, Los Angeles
- Age
- 18 years and over
- People
- 27 worldwide
- Run by
- Tanabe Pharma America, Inc.
See details and how to joinNCT06943521 - Phase 1Taking peopleDose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
- Where
- Chicago
- Age
- 18 years and over
- People
- 36
- Run by
- University of Chicago
See details and how to joinNCT06912087